JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 9, 2022

Total Value: $529M (100.0% shares, 0.0% debt)

Holdings (22)

FATE Fate Therapeutics, Inc. 24.8%
Value $131M Shares 3,379,064 Share Price $38.77 Est. Cost/Share $78.44 Unrealized @ Report Date -50.6%
LEGN Legend Biotech Corporation 11.2%
Value $59.2M Shares 1,629,173 Share Price $36.34 Est. Cost/Share $41.61 Unrealized @ Report Date -12.7%
PTGX Protagonist Therapeutics Inc. 11.0%
Value $58M Shares 2,449,183 Share Price $23.68 Est. Cost/Share $42.63 Unrealized @ Report Date -44.5%
ARWR Arrowhead Pharmaceuticals, Inc. 11.0%
Value $57.99M Shares 1,260,869 Share Price $45.99 Est. Cost/Share $64.75 Unrealized @ Report Date -29.0%
MGTX MeiraGTx Holdings plc 7.6%
Value $40.15M Shares 2,898,550 Share Price $13.85 Est. Cost/Share $13.69 Unrealized @ Report Date +1.2%
HLTHQ Cue Health, Inc. 6.8%
Value $35.79M Shares 5,548,864 Share Price $6.45 Est. Cost/Share $11.81 Unrealized @ Report Date —
PRCT Procept BioRobotics Corporation 6.7%
Value $35.64M Shares 1,018,478 Share Price $34.99 Est. Cost/Share $38.38 Unrealized @ Report Date -8.8%
— Fusion Pharmaceuticals Inc. 5.4%
Value $28.52M Shares 3,670,516 Share Price $7.77 Est. Cost/Share $7.92 Unrealized @ Report Date —
CVRX CVRx, Inc. 4.0%
Value $20.94M Shares 3,495,575 Share Price $5.99 Est. Cost/Share $19.18 Unrealized @ Report Date -68.8%
XNCR Xencor, Inc. 3.8%
Value $19.96M Shares 748,062 Share Price $26.68 Est. Cost/Share $37.91 Unrealized @ Report Date -29.6%
— Adicet Bio, Inc. 2.8%
Value $14.56M Shares 728,944 Share Price $19.97 Est. Cost/Share $7.84 Unrealized @ Report Date —
— Point Biopharma Global Inc. 1.5%
Value $7.97M Shares 1,000,000 Share Price $7.97 Est. Cost/Share $7.69 Unrealized @ Report Date —
— Vor Biopharma, Inc. 1.2%
Value $6.491M Shares 1,074,658 Share Price $6.04 Est. Cost/Share $15.68 Unrealized @ Report Date —
— BiomX Inc. 0.8%
Value $4.117M Shares 2,133,402 Share Price $1.93 Est. Cost/Share $3.06 Unrealized @ Report Date —
— SomaLogic, Inc. 0.4%
Value $2.254M Shares 281,052 Share Price $8.02 Est. Cost/Share $12.39 Unrealized @ Report Date —
— PhaseBio Pharmaceuticals, Inc. 0.4%
Value $2.121M Shares 1,607,044 Share Price $1.32 Est. Cost/Share $3.11 Unrealized @ Report Date —
NNOX Nano-X Imaging Ltd. 0.4%
Value $2.086M Shares 192,429 Share Price $10.84 Est. Cost/Share $20.72 Unrealized @ Report Date -47.7%
ALDX Aldeyra Therapeutics, Inc. 0.3%
Value $1.755M Shares 394,834 Share Price $4.44 Est. Cost/Share $9.18 Unrealized @ Report Date -51.6%
— Tracon Pharmaceuticals, Inc. 0.0%
Value $221K Shares 84,003 Share Price $2.63 Est. Cost/Share $3.87 Unrealized @ Report Date —
— Senseonics Holdings, Inc. 0.0%
Value $108K Shares 54,621 Share Price $1.98 Est. Cost/Share $3.39 Unrealized @ Report Date —
— Graybug Vision, Inc. 0.0%
Value $61,000 Shares 49,547 Share Price $1.23 Est. Cost/Share $3.31 Unrealized @ Report Date —
— Catalyst Biosciences, Inc. 0.0%
Value $44,000 Shares 66,951 Share Price $0.66 Est. Cost/Share $4.11 Unrealized @ Report Date —